Pilgat-M

Therapeutic Segment:
Anti-diabetic

Generic Name:
Sitagliptin/Metformin HCI

Description:
Sitagliptin/Metformin HCl tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: Sitagliptin and Metformin Hydrochloride.

Indication:

PILGAT-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.

Formulation:

  • Tablets

Strength:

  • 50/500mg
  • 50/1000mg

Pack Size:

  • 1 x 14s
Pilgat-M-Packshot-copy